NVTS vs. CLOV, HLLY, HYZN, MVST, ASTR, SITM, SEDG, SIMO, SMTC, and KLIC
Should you be buying Navitas Semiconductor stock or one of its competitors? The main competitors of Navitas Semiconductor include Clover Health Investments (CLOV), Holley (HLLY), Hyzon Motors (HYZN), Microvast (MVST), Astra Space (ASTR), SiTime (SITM), SolarEdge Technologies (SEDG), Silicon Motion Technology (SIMO), Semtech (SMTC), and Kulicke and Soffa Industries (KLIC).
Navitas Semiconductor (NASDAQ:NVTS) and Clover Health Investments (NASDAQ:CLOV) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.
46.1% of Navitas Semiconductor shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 31.8% of Navitas Semiconductor shares are owned by insiders. Comparatively, 22.3% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Navitas Semiconductor has a beta of 2.52, suggesting that its stock price is 152% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500.
Navitas Semiconductor received 1 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 40.74% of users gave Navitas Semiconductor an outperform vote while only 39.62% of users gave Clover Health Investments an outperform vote.
Navitas Semiconductor has higher earnings, but lower revenue than Clover Health Investments. Navitas Semiconductor is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.
Navitas Semiconductor presently has a consensus price target of $7.41, suggesting a potential upside of 89.62%. Clover Health Investments has a consensus price target of $1.50, suggesting a potential upside of 36.36%. Given Navitas Semiconductor's stronger consensus rating and higher probable upside, analysts plainly believe Navitas Semiconductor is more favorable than Clover Health Investments.
Clover Health Investments has a net margin of -8.63% compared to Navitas Semiconductor's net margin of -97.75%. Navitas Semiconductor's return on equity of -21.22% beat Clover Health Investments' return on equity.
In the previous week, Clover Health Investments had 6 more articles in the media than Navitas Semiconductor. MarketBeat recorded 10 mentions for Clover Health Investments and 4 mentions for Navitas Semiconductor. Navitas Semiconductor's average media sentiment score of 0.58 beat Clover Health Investments' score of 0.12 indicating that Navitas Semiconductor is being referred to more favorably in the media.
Summary
Navitas Semiconductor beats Clover Health Investments on 12 of the 18 factors compared between the two stocks.
Get Navitas Semiconductor News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Navitas Semiconductor Competitors List
Related Companies and Tools
